Results 51 to 60 of about 491 (150)

Efficacy of undenatured and hydrolyzed type II collagen in the treatment of pain syndrome

Russian Medical Inquiry, 2022
Collagens play an important structural role and contribute to the mechanical properties, organization and shape of tissues. In musculoskeletal system diseases (MSD), the amount of type II collagen in the cartilage extracellular matrix significantly decreases. Degradation and reduction of type II collagen are associated with osteoarthritis (OA).
O.A. Shavlovskaya, I.A. Bokova, I.D. Romanov, N.I. Shavlovsky   +3 more
openaire   +1 more source

Role of undenatured collagen type ii in management of osteoarthritis: A hospital based study [PDF]

International Journal of Orthopaedics Sciences, 2020
Osteoarthritis knee is a degenerative disease, predominantly seen in the elderly population, which caused by the destruction of the articular cartilage. The extra cellular matrix of the articular cartilage is predominantly made up of water, collagen, proteoglycans and other proteins.
Dr. Sathik Babu, Dr. Pradeep Elangovan, Dr. Dinesh Kumar S   +2 more
openaire   +1 more source

SAFETY AND EFFICACY OF UNDENATURED TYPE II COLLAGEN IN OSTEOARTHRITIS

The FASEB Journal, 2009
Osteoarthritis is a degenerative joint disease causing inflammation and wear and tear of joint cartilage. UC‐II is an undenatured type II collagen derived from chicken sternum cartilage. Studies have shown efficacy of UC‐II in animal and human with a small convenient daily dose of 40 mg ...
Debasis Bagchi, Manashi Bagchi, Ramesh C. Gupta   +2 more
openaire   +1 more source

Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity

Неврология, нейропсихиатрия, психосоматика, 2023
Understanding the major pathological pathways and the key molecules involved in the pathogenesis of inflammatory processes in joints, particularly in osteoarthritis (OA), is crucial for drug and pharmaconutraceuticals development.
O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova   +3 more
doaj   +1 more source

The Study of undenatured type II collagen in the knee osteoarthri [PDF]

International Journal of Orthopaedics Traumatology & Surgical Sciences, 2019
Introduction: Medical management of osteoarthritis has evovlved considerably over last two decades. The purpose of the present study was to asses the outcome of collagen type II IN osteoarthritis of knee joint. Methods: one hundred randomly selected patients who received a daily dose of UC-II (40 mg) for 120 days.
openaire   +1 more source

Extraction of chondroitin sulfate and type II collagen from sturgeon (Acipenser gueldenstaedti) notochord and characterization of their hybrid fibrils [PDF]

, 2023
Chondroitin sulfate (CS) and undenatured type II collagen (Col II) are the two major, biological macromolecules of cartilage-related tissues. In this study, a new extraction. process was developed to obtain CS and Col II simultaneously.
Wei, Qiwei, Meng, Dawei, Leng, Xiaoqian, Du, Hao, Dai, Zhiyuan, Li, Wen, Takagi, Yasuaki   +6 more
core   +1 more source

Pharmaconutraceutical Chondroguard®TRIO – a new ideology for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the First Multidisciplinary Bilateral Russia – Uzbekistan Expert Council

Современная ревматология, 2023
On April 1, 2023, experts presented a resolution of the First Multidisciplinary Bilateral Russia–Uzbekistan Expert Council, dedicated to innovations in the prediction and personalized prevention of degenerative-dystrophic diseases of the joints and spine,
article Editorial
doaj   +1 more source

Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. [PDF]

Nutr J, 2016
BackgroundUndenatured type II collagen (UC-II) is a nutritional supplement derived from chicken sternum cartilage. The purpose of this study was to evaluate the efficacy and tolerability of UC-II for knee osteoarthritis (OA) pain and associated symptoms ...
Lugo JP, Saiyed ZM, Lane NE.
europepmc   +2 more sources

Consistent use injectable and oral chondroprotectors in patients with osteoarthritis and lower back pain. Case report [PDF]

Consilium Medicum
Osteoarthritis (OA) is a disease of the entire joint, including structural changes in hyaline articular cartilage, subchondral bone, ligaments, capsule, synovial membrane and periarticular muscles.
Olga A. Shavlovskaya, Igor D. Romanov, Irina A. Bokova   +2 more
doaj   +1 more source

New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council

Неврология, нейропсихиатрия, психосоматика, 2023
In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council presented
Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova   +34 more
doaj   +1 more source